SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-189499
Filing Date
2024-07-31
Accepted
2024-07-31 07:44:08
Documents
6
Effectiveness Date
2024-07-31

Document Format Files

Seq Description Document Type Size
1 S-8 d769908ds8.htm S-8 28426
2 EX-5.1 d769908dex51.htm EX-5.1 6501
3 EX-23.2 d769908dex232.htm EX-23.2 1553
4 EX-FILING FEES d769908dexfilingfees.htm EX-FILING FEES 14347
5 GRAPHIC g769908dsp06.jpg GRAPHIC 20823
6 GRAPHIC g769908g0727031656646.jpg GRAPHIC 1579
  Complete submission text file 0001193125-24-189499.txt   83106
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281118 | Film No.: 241159913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)